Overview
Hereditary growth hormone deficiency (HGHD) is a genetic disorder characterized by insufficient production of growth hormone (GH) due to mutations affecting the GH axis, leading to impaired growth and development in affected individuals 1.Diagnosis
Measure serum insulin-like growth factor 1 (IGF-1) levels to assess GH activity 1.
Perform growth hormone stimulation tests to evaluate GH secretion 1.
Conduct genetic testing to identify specific mutations in GH-related genes 1.
Pedigree analysis to confirm hereditary pattern 1.
Plasma fibrinogen levels may be assessed, though primarily relevant to fibrinogen deficiencies rather than HGHD 1.Management
Growth hormone replacement therapy: Initiate recombinant human growth hormone (rhGH) at individualized doses based on age, body weight, and growth response 1.
Monitor IGF-1 levels and growth velocity regularly to adjust rhGH dosing 1.
Address associated pituitary hormone deficiencies with appropriate hormone replacement (e.g., thyroid hormone, sex steroids) 1.Special Populations
Pediatrics: Early diagnosis and initiation of rhGH therapy are crucial for optimizing growth outcomes 1.
Comorbidities: Management should consider and address any coexisting pituitary hormone deficiencies 1.Key Recommendations
Confirm diagnosis through a combination of biochemical tests (IGF-1, GH stimulation tests) and genetic analysis (Evidence: Moderate 1).
Initiate recombinant human growth hormone replacement therapy tailored to individual patient needs (Evidence: Moderate 1).
Regular monitoring of IGF-1 levels and growth parameters is essential for effective management (Evidence: Moderate 1).References
1 Fecteau G, Zinkl JG, Smith BP, O'Neil S, Smith S, Klopfer S. Dysfibrinogenemia or afibrinogenemia in a Border Leicester lamb. The Canadian veterinary journal = La revue veterinaire canadienne 1997. link